ROCHESTER, Minn. — A Rochester man who received a kidney transplant in 2023 and now faces life-and-death consequences after being taken into U.S. Immigration and Customs Enforcement (ICE) custody has ignited a fierce debate over medical care for detainees, after his family and lawmakers say he went days without consistent access to crucial anti-rejection medication.
Detention, Transfer, and Family Alarm
On February 5, 2026, ICE agents apprehended 38-year-old Javier Abreu-Vasquez while he was delivering groceries for a church-affiliated mutual-aid group in Rochester, according to family friends and state officials. Witnesses say the arrest was abrupt and forceful, with the vehicle Abreu-Vasquez was driving reportedly struck during the encounter.
Within a day of his detention, federal authorities transferred Abreu-Vasquez to an ICE processing facility in El Paso, Texas. During the transfer process and after reaching the facility, family members say Abreu-Vasquez reported that his immunosuppressant medication — vital to preventing his body from rejecting his transplanted kidney — was not being administered reliably.
According to his family’s account, Abreu-Vasquez went more than four days with missed or substantially delayed doses of his medication — a risk that could lead to serious health complications, including organ rejection and potentially fatal outcomes if left uncorrected.
Family and Lawmakers Push Back
State Representative Kim Hicks (D-Minn.), who has been in contact with the family, raised the alarm about the medication gaps and difficulties in communicating with federal authorities. Hicks personally delivered Abreu-Vasquez’s medication and supporting medical documentation from the Mayo Clinic to ICE officials in Minneapolis — only to be told that a doctor’s note was required before the medication could be accepted for delivery to Abreu-Vasquez.
“We were told he was already receiving his medications, but that appears to have been untrue,” Hicks told reporters. She described attempts to ascertain his status as “a game of telephone,” with conflicting information coming from ICE about his condition and care.
Abreu-Vasquez’s wife, Carolina Rosario De Abreu, echoed these concerns, saying she has struggled to confirm where her husband is being held and whether he is getting the critical medicine he needs.
Federal Response: Care Is Being Provided
In official statements, the Department of Homeland Security (DHS) — which oversees ICE — has acknowledged Abreu-Vasquez’s recent transplant and stated that he “received his medication within hours of entering ICE custody.” DHS Assistant Secretary Tricia McLaughlin noted that the agency was “working with the family to ensure he gets all of his needed medications.”
McLaughlin added that ICE has longstanding practices in place to screen detainees’ health needs, provide intake medical assessments, and offer ongoing care, including emergency treatment, dental services, and mental health support. The statement also claimed that ICE detention facilities deliver “the best healthcare many aliens have received in their entire lives.”
Yet the family disputes the adequacy of these assurances, pointing to missed morning doses and timing issues that could jeopardize Abreu-Vasquez’s transplanted kidney. According to relatives, even after arriving in Texas, the timing and consistency of his immunosuppressant doses remain uncertain.
Medical Risk and Humanitarian Concerns
Medical experts universally agree that transplant patients require strict adherence to immunosuppressant regimens to prevent rejection of the transplanted organ. Even short interruptions or irregular dosing can trigger immune responses that damage or destroy the organ, often requiring more intensive medical intervention or a second transplant — outcomes with significant risk and cost. Transplant centers typically emphasize seamless continuity of care, especially during transitions between healthcare settings.
The Mayo Clinic, where Abreu-Vasquez received his transplant in 2023, provided clinical documentation supporting the need for ongoing, timely medication — a requirement his advocates delivered to federal officials.
Legal Status and Broader Controversy
ICE’s characterization of Abreu-Vasquez in its statement as an “illegal alien” has drawn scrutiny from local officials. Representative Hicks pointed out that he has an alien registration number, a designation issued by U.S. authorities and often held by noncitizens residing and working in the country legally during immigration proceedings.
The case has also intensified broader debates around immigration enforcement practices, particularly amid heightened ICE activity in Minnesota and other states. Advocates have raised concerns about the treatment of medically vulnerable individuals in detention, while immigration authorities maintain they are conducting lawful operations and ensuring detainee care.
Public Reaction and Next Steps
The situation has sparked protests and social media outcry from community members, civil rights groups, and transplant patient networks who say the treatment of Abreu-Vasquez reflects systemic issues in the care of detained immigrants with serious health needs. Some experts have suggested the case could prompt legal action or calls for humanitarian release on medical grounds.
Family members continue to seek clarity on Abreu-Vasquez’s condition, medication schedule, and potential avenues for securing his timely return to Minnesota or placement in a facility equipped to manage his healthcare needs without disruption.
As the story develops, advocates are calling on federal authorities to publicly clarify detainee medical protocols and ensure transparent communication with families of those in ICE custody.